MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in MAIA Biotechnology, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q4 2023
- Shares held
- 660.9K
- −142.4K (−17.7%) vs. Q4 2023
- Total value
- $1.50M
- +$545.0K (+56.9%) vs. Q4 2023
- New holders
- 3
- 6 more added
- Sold out
- 5
- 7 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 281,682 | $619.7K | 0.00% | +107,523+61.7% | Added |
| Centric Wealth Management | 67,198 | $196.9K | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 53,257 | $117.2K | 0.00% | +8,700+19.5% | Added |
| Bridgeway Capital Management, LLC | 45,700 | $100.5K | 0.00% | −30,000−39.6% | Reduced |
| Virtu Financial LLC | 32,487 | $71.0K | 0.01% | +32,487 | New |
| Jane Street Group, LLC | 25,065 | $55.1K | 0.00% | +25,065 | New |
| Citadel Advisors LLC | 23,749 | $52.2K | 0.00% | −33,724−58.7% | Reduced |
| Naviter Wealth, LLC | 22,168 | $48.8K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 21,300 | $46.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 20,273 | $44.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 19,000 | $42.0K | 0.00% | −92,200−82.9% | Reduced |
| BlackRock Inc. | 16,992 | $37.4K | 0.00% | −217−1.3% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 16,000 | $35.2K | 0.00% | +1,200+8.1% | Added |
| Morgan Stanley | 10,095 | $22.2K | 0.00% | +5,000+98.1% | Added |
| Tower Research Capital LLC (TRC) | 5,665 | $12.5K | 0.00% | +2,071+57.6% | Added |
| Sunbelt Securities, Inc. | 100 | $220 | 0.00% | −50−33.3% | Reduced |
| Wells Fargo & Company | 91 | $200 | 0.00% | +22+31.9% | Added |
| JPMorgan Chase & Co | 38 | $84 | 0.00% | −40−51.3% | Reduced |
| Mather Group, LLC. | 24 | $28 | 0.00% | +24 | New |
| Royal Bank of Canada | 28 | $0 | 0.00% | −120−81.1% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −130,510−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,965−100.0% | Sold out |
| Brookstone Capital Management | 0 | $0 | 0.00% | −12,658−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −998−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −8−100.0% | Sold out |